US Patent 11643434 Neuroactive steroids and compositions thereof
Patent 11643434 was granted and assigned to SAGE Therapeutics on May, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 29, 2020
0
Date of Patent
May 9, 2023
0
Patent Applicant
Patent Application Number
16887887
0
Patent Inventor Names
Francesco G. Salituro
0
Maria Jesus Blanco-Pillado
0
Marshall Lee Morningstar
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11643434 Neuroactive steroids and compositions thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.